CLINICAL_TRIALS
trial_result
· 2019-05-15
Clinical Trial Update: Effect of the GSK2245035 on the Allergen-induced Asthmatic Response [Phase 2]
Summary
Phase 2 trial assessing the effect of GSK2245035 on allergen-induced asthmatic response has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2019-05-15